H.R. 7007 117th Congress
COVID Supplemental Appropriations Act, 2022
- Health
- Sponsor: Rep. DeLauro, Rosa L. [D-CT-3]
- Congress.gov ↗
Latest action, Mar 9, 2022: Rule H. Res. 973 passed House.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
Sponsor
Sponsored by Rep. DeLauro, Rosa L. [D-CT-3] (Democrat). No cosponsors.
Referred to: House: Appropriations Committee; House: Budget Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
AMERICAN MEDICAL ASSOCIATION
AVENUE SOLUTIONS
4 reports
BLUE CROSS BLUE SHIELD ASSOCIATION
AVENUE SOLUTIONS
4 reports
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC.
AVENUE SOLUTIONS
4 reports
ILLUMINA, INC.
AVENUE SOLUTIONS
4 reports
MODERNA, INC.
AVENUE SOLUTIONS
4 reports
4 reports
PFIZER INC
OGR
4 reports
3 reports
GAINWELL TECHNOLOGIES
AVENUE SOLUTIONS
3 reports
HCA HEALTHCARE
MEHLMAN CONSULTING, INC.
3 reports
NATIONAL ASSOCIATION OF CHAIN DRUG STORES
PRIME POLICY GROUP
3 reports
All 25 of 50 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| AMERICAN MEDICAL ASSOCIATION | AVENUE SOLUTIONS | 4 | $0 | Q1 2022 | Q3 2022 | yes |
| ASCENSION HEALTH ALLIANCE D/B/A ASCENSION | 4 | $1.6M | Q1 2022 | Q3 2022 | yes | |
| ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 4 | $3.8M | Q1 2022 | Q3 2022 | yes | |
| BLUE CROSS BLUE SHIELD ASSOCIATION | AVENUE SOLUTIONS | 4 | $0 | Q1 2022 | Q3 2022 | yes |
| DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. | AVENUE SOLUTIONS | 4 | $280K | Q1 2022 | Q3 2022 | yes |
| ILLUMINA, INC. | AVENUE SOLUTIONS | 4 | $0 | Q1 2022 | Q3 2022 | yes |
| MODERNA, INC. | AVENUE SOLUTIONS | 4 | $200K | Q1 2022 | Q3 2022 | yes |
| NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 4 | $1.1M | Q1 2022 | Q3 2022 | yes | |
| NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE | 4 | $880K | Q1 2022 | Q3 2022 | yes | |
| NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE | MARIA FREESE | 4 | $0 | Q1 2022 | Q3 2022 | yes |
| PFIZER INC | OGR | 4 | $0 | Q1 2022 | Q3 2022 | yes |
| AMERICAN CLINICAL LABORATORY ASSN | 3 | $2.5M | Q1 2022 | Q3 2022 | yes | |
| GAINWELL TECHNOLOGIES | AVENUE SOLUTIONS | 3 | $210K | Q1 2022 | Q3 2022 | yes |
| HCA HEALTHCARE | MEHLMAN CONSULTING, INC. | 3 | $0 | Q1 2022 | Q3 2022 | yes |
| NATIONAL ASSOCIATION OF CHAIN DRUG STORES | PRIME POLICY GROUP | 3 | $0 | Q4 2022 | Q3 2022 | yes |
| AMERICAN COLLEGE OF PHYSICIAN SERVICES, INC. | 2 | $603K | Q4 2022 | Q3 2022 | yes | |
| AMERICAN COLLEGE OF PHYSICIANS | 2 | $138K | Q4 2022 | Q3 2022 | yes | |
| EXPERIENTIAL DESIGNERS AND PRODUCERS ASSOCIATION | CASSIDY & ASSOCIATES, INC. | 2 | $60K | Q1 2022 | Q2 2022 | yes |
| GLAXOSMITHKLINE | W STRATEGIES, LLC | 2 | $80K | Q1 2022 | Q2 2022 | yes |
| KAISER FOUNDATION HEALTH PLAN INC | 2 | $2.9M | Q1 2022 | Q2 2022 | yes | |
| VIR BIOTECHNOLOGY, INC. | W STRATEGIES, LLC | 2 | $0 | Q1 2022 | Q2 2022 | yes |
| AEGIS SCIENCES CORPORATION | MEHLMAN CONSULTING, INC. | 1 | $30K | Q1 2022 | Q1 2022 | yes |
| AMEDISYS HOME HEALTH AND HOSPICE CARE | AVENUE SOLUTIONS | 1 | $80K | Q1 2022 | Q1 2022 | yes |
| AMERICAN MEDICAL ASSOCIATION | LOPER CONSULTING LLC | 1 | $0 | Q1 2022 | Q1 2022 | yes |
| ASCENSION HEALTH ALLIANCE | MEHLMAN CONSULTING, INC. | 1 | $50K | Q1 2022 | Q1 2022 | yes |